Lactobacillus pentosus var. plantarum C29 ameliorates age-dependent memory impairment in Fischer 344 rats

Letters in Applied Microbiology

Volumn 60, Issue 4, 2015, Pages 307-314

  Jeong, J J ^a   Woo, J Y ^a   Kim, K A ^a   Han, M J ^a   Kim, D H ^a  

^a Kyung Hee University   (South Korea)

Author keywords

Ageing; Inflammaging; Lactobacillus pentosus var. plantarum; Memory

Indexed keywords

CHEMICAL ACTIVATION; LACTIC ACID; NITRIC OXIDE; RESTORATION; VALUE ENGINEERING;

ANTI-INFLAMMATORY EFFECTS; BRAIN-DERIVED NEUROTROPHIC FACTORS; CAMP-RESPONSE ELEMENT-BINDING PROTEINS; INFLAMMAGING; LACTIC ACID BACTERIA; LACTOBACILLUS PENTOSU VAR.; ORAL ADMINISTRATION; PLANTARUM; PROTEIN ACTIVATION; TRAINING SESSIONS;

RATS;

BRAIN DERIVED NEUROTROPHIC FACTOR; C29; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; CYCLOOXYGENASE 2; DOUBLECORTIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDUCIBLE NITRIC OXIDE SYNTHASE; MAMMALIAN TARGET OF RAPAMYCIN; PROBIOTIC AGENT; PROTEIN KINASE B; PROTEIN P16; UNCLASSIFIED DRUG; ANTIINFLAMMATORY AGENT; CREBBP PROTEIN, RAT; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN BINDING PROTEIN; CYCLIN DEPENDENT KINASE INHIBITOR 2A; DOUBLECORTIN PROTEIN; MICROTUBULE ASSOCIATED PROTEIN; MTOR PROTEIN, RAT; NEUROPEPTIDE; TARGET OF RAPAMYCIN KINASE;

AGE; BACTERIUM; GENE EXPRESSION; LABORATORY METHOD; NITRIC OXIDE; REMEDIATION; RODENT; SIGNALING;

AGING; ANIMAL CELL; ANIMAL CELL CULTURE; ANIMAL EXPERIMENT; ANTIINFLAMMATORY ACTIVITY; ARTICLE; BACTERIAL STRAIN; CONTROLLED STUDY; ENZYME ACTIVATION; FISCHER 344 RAT; HIPPOCAMPUS; LACTOBACILLUS; LACTOBACILLUS PENTOSUS PLANTARUM; MALE; MEMORY DISORDER; NONHUMAN; PERITONEUM MACROPHAGE; PROTEIN EXPRESSION; RAT; SWIMMING; ANIMAL; ANTAGONISTS AND INHIBITORS; BIOSYNTHESIS; C57BL MOUSE; DEMENTIA; LACTOBACILLUS PLANTARUM; MAZE TEST; MEMORY; MEMORY DISORDERS; METABOLISM; MOUSE; PATHOLOGY; PHYSIOLOGY; SIGNAL TRANSDUCTION;

LACTOBACILLUS PENTOSUS; RATTUS;

AGING; ANIMALS; ANTI-INFLAMMATORY AGENTS; BRAIN-DERIVED NEUROTROPHIC FACTOR; CREB-BINDING PROTEIN; CYCLIN-DEPENDENT KINASE INHIBITOR P16; CYCLOOXYGENASE 2; DEMENTIA; ENZYME ACTIVATION; HIPPOCAMPUS; LACTOBACILLUS PLANTARUM; MALE; MAZE LEARNING; MEMORY; MEMORY DISORDERS; MICE; MICE, INBRED C57BL; MICROTUBULE-ASSOCIATED PROTEINS; NEUROPEPTIDES; NF-KAPPA B; NITRIC OXIDE SYNTHASE TYPE II; PROTO-ONCOGENE PROTEINS C-AKT; RATS; RATS, INBRED F344; SIGNAL TRANSDUCTION; TOR SERINE-THREONINE KINASES;

EID: 84924811261     PISSN: 02668254     EISSN: 1472765X     Source Type: Journal    
DOI: 10.1111/lam.12393     Document Type: Article

References (26)

1. Alonso-Fernández, P. and De la Fuente, M. (2011) Role of the immune system in aging and longevity. Curr Aging Sci 4, 78-1002.
2. Bubici, C., Papa, S., Dean, K. and Franzoso, G. (2006) Mutual cross-talk between reactive oxygen species and nuclear factor-kappa B: molecular basis and biological significance. Oncogene 25, 6731-6748.
3. Cammarota, G., Ianiro, G., Bibbò, S. and Gasbarrini, A. (2014) Gut microbiota modulation: probiotics, antibiotics or fecal microbiota transplantation? Intern Emerg Med 9, 365-373.
4. Campieri, M. and Gionchetti, P. (1999) Probiotics in inflammatory bowel disease: new insight to pathogenesis or a possible therapeutic alternative? Gastroenterology 116, 1246-1249.
5. Chapple, I.L. (1997) Reactive oxygen species and antioxidants in inflammatory diseases. J Clin Periodontol 24, 287-296.
6. Chung, H., Lee, E., Choi, Y., Kim, J., Kim, D., Zou, Y., Kim, C., Lee, J. et al. (2011) Molecular inflammation as an underlying mechanism of the aging process and age-related diseases. J Dent Res 90, 830-840.
7. Collins, M.D. and Gibson, G.R. (1999) Probiotics, prebiotics, and synbiotics: approaches for modulating the microbial ecology of the gut. Am J Clin Nutr 69, 1052s-1057s.
8. Craft, S. (2005) Insulin resistance syndrome and Alzheimer's disease: age-and obesity-related effects on memory, amyloid, and inflammation. Neurobiol Aging 26, 65-69.
9. Doody, R.S. (1999) Therapeutic standards in Alzheimer disease. Alzheimer Dis Assoc Disord 13, S20-S26.
10. Fitzgerald, P.J., Seemann, J.R. and Maren, S. (2014) Can fear extinction be enhanced? A review of pharmacological and behavioral findings. Brain Res Bull 105, 46-60.
11. Harman, D. (2001) Aging: overview. Ann N Y Acad Sci 928, 1-21.
12. Hirsch, E., Breidert, T., Rousselet, E., Hunot, S., Hartmann, A. and Michel, P. (2003) The role of glial reaction and inflammation in Parkinson's disease. Ann N Y Acad Sci 991, 214-228.
13. Hong, S.W., Yoo, D.H., Woo, J.Y., Jeong, J.J., Yang, J.H. and Kim, D.H. (2014) Soyasaponins Ab and Bb prevent scopolamine-induced memory impairment in mice without the inhibition of acetylcholinesterase. J Agric Food Chem 62, 2062-2068.
14. Jang, S.E., Han, M.J., Kim, S.Y. and Kim, D.H. (2014) Lactobacillus plantarum CLP-0611 ameliorates colitis in mice by polarizing M1 to M2-like macrophages. Int Immunopharmacol 21, 186-192.
15. Joh, E.H. and Kim, D.H. (2011) Kalopanaxsaponin A ameliorates experimental colitis in mice by inhibiting IRAK-1 activation in the NF-κB and MAPK pathways. Br J Pharmacol 162, 1731-1742.
16. Jung, I.H., Jung, M.A., Kim, E.J., Han, M.J. and Kim, D.H. (2012) Lactobacillus pentosus var. plantarum C29 protects scopolamine-induced memory deficit in mice. J Appl Microbiol 113, 1498-1506.
17. Luine, V. and Frankfurt, M. (2013) Interactions between estradiol, BDNF and dendritic spines in promoting memory. Neuroscience 239, 34-45.
18. McGeer, E.G. and McGeer, P.L. (1999) Brain inflammation in Alzheimer disease and the therapeutic implications. Curr Pharm Des 5, 821-836.
19. McKhann, G.M., Knopman, D.S., Chertkow, H., Hyman, B.T., Jack, C.R. Jr, Kawas, C.H., Klunk, W.E., Koroshetz, W.J. et al. (2011) The diagnosis of dementia due to Alzheimer's disease: recommendations from the national institute on aging-Alzheimer's association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement 7, 263-269.
20. Neff, F., Flores-Dominguez, D., Ryan, D.P., Horsch, M., Schröder, S., Adler, T., Afonso, L.C., Aguilar-Pimentel, J.A. et al. (2013) Rapamycin extends murine lifespan but has limited effects on aging. J Clin Invest 123, 3272-3291.
21. Salminen, S., von Wright, A., Morelli, L., Marteau, P., Brassart, D., de Vos, W.M., Fondén, R., Saxelin, M. et al. (1998) Demonstration of safety of probiotics - a review. Int J Food Microbiol 44, 93-106.
22. Sarter, M. and Bruno, J.P. (2004) Developmental origins of the age-related decline in cortical cholinergic function and associated cognitive abilities. Neurobiol Aging 25, 1127-1139.
23. Tabuchi, M., Ozaki, M., Tamura, A., Yamada, N., Ishida, T., Hosoda, M. and Hosono, A. (2003) Antidiabetic effect of lactobacillus GG in streptozotocin-induced diabetic rats. Biosci Biotechnol Biochem 67, 1421-1424.
24. Terry, A.V. and Buccafusco, J.J. (2003) The cholinergic hypothesis of age and Alzheimer's disease-related cognitive deficits: recent challenges and their implications for novel drug development. J Pharmacol Exp Ther 306, 821-827.
25. Woo, J.Y., Gu, W., Kim, K.A., Jang, S.E., Han, M.J. and Kim, D.H. (2014) Lactobacillus pentosus var. plantarum C29 ameliorates memory impairment and inflammaging in a D-galactose-induced accelerated aging mouse model. Anaerobe 27, 22-26.
26. Yu, B.P. and Yang, R. (1996) Critical evaluation of the free radical theory of aging. Ann N Y Acad Sci 786, 1-11.